Verition Fund Management
CMRAW

Verition Fund Management’s Comera Life Sciences Holdings, Inc. Warrant expiring 5/19/2027 CMRAW Stock Holding History

Verition Fund Management’s Portfolio CMRAW Stock Details CMRAW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-17,500
Closed -$315 – 2799
2023
Q3 		$315 Hold
17,500
– – ﹤0.01% 2297
2023
Q2 		$520 Hold
17,500
– – ﹤0.01% 2153
2023
Q1 		$977 Hold
17,500
– – ﹤0.01% 2110
2022
Q4 		$835 Hold
17,500
– – ﹤0.01% 2047
2022
Q3 		$1K Hold
17,500
– – ﹤0.01% 3014
2022
Q2 		$46K Buy
+17,500
New +$2.87K ﹤0.01% 2158

Other funds holding CMRAW

LP
LMR Partners London, United Kingdom $45.4B AUM 60.68% 1-Year Est. Return
RCM
Rivernorth Capital Management West Palm Beach, Florida $2B AUM 0.66% 1-Year Est. Return
CS
Clear Street New York $24.6B AUM 56.26% 1-Year Est. Return

Verition Fund Management's CMRAW Position: Q4 2023 in Review

Verition Fund Management sold out of Comera Life Sciences Holdings, Inc. Warrant expiring 5/19/2027 (CMRAW) in Q4 2023, closing a stake of 17,500 shares — an estimated $315 sold.

Verition Fund Management first reported a position in CMRAW in Q2 2022 and held it in 6 quarters. The position peaked at $46K in Q2 2022. 3 funds tracked by Wall St. Rank hold CMRAW as of Q4 2023.

  • Verition Fund Management reported no remaining Comera Life Sciences Holdings, Inc. Warrant expiring 5/19/2027 position as of Q4 2023 after selling out during the quarter.
  • Verition Fund Management sold 17,500 Comera Life Sciences Holdings, Inc. Warrant expiring 5/19/2027 shares in Q4 2023, an estimated $315.
  • Verition Fund Management first reported a position in Comera Life Sciences Holdings, Inc. Warrant expiring 5/19/2027 in Q2 2022 and held it in 6 quarters.
  • Verition Fund Management's Comera Life Sciences Holdings, Inc. Warrant expiring 5/19/2027 position peaked at $46K in Q2 2022.
  • 3 funds tracked by Wall St. Rank held Comera Life Sciences Holdings, Inc. Warrant expiring 5/19/2027 as of Q4 2023.

Based on Verition Fund Management's 13F filing for Q4 2023, filed 14 Feb 2024.